N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitors.
La Rosa C, Sharma P, Junaid Dar M, Jin Y, Qin L, Roy A, Kendall A, Wu M, Lin Z, Uchenik D, Li J, Basu S, Moitra S, Zhang K, Zhuo Wang M, Werbovetz KA.
La Rosa C, et al. Among authors: uchenik d.
Bioorg Med Chem. 2024 Nov 1;113:117907. doi: 10.1016/j.bmc.2024.117907. Epub 2024 Sep 6.
Bioorg Med Chem. 2024.
PMID: 39288704